Aytu BioPharma (AYTU) reported fiscal 2026 fourth-quarter net revenue of $16.1 million, up 6.4% from $15.1 million a year earlier. GAAP net loss was $15,000, or $0.00 per basic and diluted share, compared with a $19.8 million loss in the prior-year quarter.
For fiscal 2026, revenue totaled $57.6 million, down 13.3% from $66.4 million in fiscal 2025, while the company reported a GAAP net loss of $14.3 million, or $1.16 per share. Cash and cash equivalents were $26.3 million at June 30, 2026.
- EXXUA generated $3.9 million in fourth-quarter revenue and $6.6 million for fiscal 2026.
- Fourth-quarter EXXUA prescriptions totaled 3,323, up about 138% from 1,398 in the third quarter.
- ADHD Portfolio revenue was $10.4 million in the quarter, versus $13.1 million a year earlier.
- Pediatric Portfolio revenue was $1.8 million, compared with $2.0 million in the prior-year quarter.
- Fourth-quarter adjusted EBITDA was $0.5 million; full-year adjusted EBITDA was a loss of $3.7 million.
$AYTU Hedge Fund Activity
We have seen 15 institutional investors add shares of $AYTU stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIADEMA PARTNERS LP removed 157,242 shares (-51.4%) from their portfolio in Q2 2026, for an estimated $338,070
- CROWN ADVISORS MANAGEMENT, INC. added 55,000 shares (+37.9%) to their portfolio in Q2 2026, for an estimated $118,250
- PERSISTENT ASSET PARTNERS LTD removed 54,913 shares (-59.1%) from their portfolio in Q2 2026, for an estimated $118,062
- ARETE WEALTH ADVISORS, LLC added 49,549 shares (+inf%) to their portfolio in Q1 2026, for an estimated $135,268
- DRW SECURITIES, LLC removed 29,368 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $80,174
- STONEPINE CAPITAL MANAGEMENT, LLC removed 21,415 shares (-2.6%) from their portfolio in Q1 2026, for an estimated $58,462
- CITADEL ADVISORS LLC added 21,290 shares (+136.9%) to their portfolio in Q1 2026, for an estimated $58,121
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.